Cite
HARVARD Citation
Fukuoka, K. et al. (n.d.). MEDB-30. Subclassification of Group 3/4 medulloblastoma as a potential prognostic biomarker to reduce the dose of craniospinal irradiation in patients with metastatic tumors: A Japanese Pediatric Molecular Neuro-Oncology Group study. Neuro-oncology. p. i111. [Online].